Investors in Apogee Enterprises, Inc. APOG need to pay close attention to the stock based on moves in the options market ...
NORTH CHICAGO, Ill. and SAN FRANCISCO and BOSTON, June 22, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Apogee Therapeutics (NASDAQ: APGE) ("Apogee") today announced they have entered into a ...
Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that Christopher W. Ede has been appointed President of the Company's Architectural Glass segment. Prior to his appointment, Ede served as Vice ...
Detailed price information for Apogee Entrpr Inc (APOG-Q) from The Globe and Mail including charting and trades.
AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results